Starling Oncology, Inc.: net_income
| Value | {"amount": 152000, "concept": "us-gaap:NetIncomeLoss", "currency": "USD"} |
|---|---|
| Period | 2022-01-01 – 2022-12-31 |
| Status | current |
| Entity | Starling Oncology, Inc. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T18:08:38.724184+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/d06ba6d7-462d-40ba-86e9-207094e60a1c
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001628280-23-008315Retrieved: 2026-08-19T18:08:38.724184+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001799191/net-income/2022-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/d06ba6d7-462d-40ba-86e9-207094e60a1c
History
- no predecessors — first report